IgA nephropathy trials in United Kingdom

In United Kingdom 12 Also abroad 92

12 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Where
Birmingham, Canterbury, Hull, Leicester, London, Nottingham, Preston, Sheffield
Age
18 years and over
People
347 worldwide
Run by
Takeda
See details and how to joinNCT06963827 · EU 2025-520825-19-00
Phase 2Taking people
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Where
Leicester, Newcastle upon Tyne
Age
18 years and over
People
45 worldwide
Run by
ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06989359
No phaseEnrolling by invitation
Mediators of Loin Pain in IgA Nephropathy
Where
Leicester
Age
18 years and over
People
40
Run by
University of Leicester
See details and how to joinNCT07649538
Phase 3Taking people
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Where
Leicester, London, Preston, Sheffield, Stoke-on-Trent
Age
18 years and over
People
454 worldwide
Run by
Biogen
See details and how to joinNCT06935357 · EU 2024-519345-30-00
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Cambridge, Leicester, London, Newcastle upon Tyne, Salford
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 1/2Taking people
PS-002 for the Treatment of IgA Nephropathy in Adults
Where
Bristol, Cardiff, Edinburgh, Leicester, London, Manchester, Nottingham
Age
18 years and over
People
32 worldwide
Run by
Purespring Therapeutics Limited
See details and how to joinNCT07182227 · EU 2025-523201-14-00
Phase 2Taking people
Study of WAL0921 in Patients With Glomerular Kidney Diseases
Where
Derby, Leicester, London, Manchester, Salford
Age
18 years to 75 years
People
96 worldwide
Run by
Walden Biosciences
See details and how to joinNCT06466135
Phase 1Taking people
Study of BHV-1400 in IgA Nephropathy
Where
Leicester
Age
18 years to 65 years
People
20 worldwide
Run by
Biohaven Therapeutics Ltd.
See details and how to joinNCT07054684
Phase 2Taking people
A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
Where
Cambridge, Cardiff, Edinburgh, Leicester, London, Salford
Age
18 years and over
People
24
Run by
University of Leicester
See details and how to joinNCT04663204
Phase 2Taking people
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Where
Bristol, Glasgow, Liverpool, London, Manchester
Age
1 year to 17 years
People
67 worldwide
Run by
Travere Therapeutics, Inc.
See details and how to joinNCT05003986 · EU 2023-505497-14-00
Phase 2/3Enrolling by invitation
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
Where
Leicester, London
Age
18 years and over
People
600 worldwide
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT05248659
No phaseTaking people
National Registry of Rare Kidney Diseases
Where
Bristol
People
35,000
Run by
UK Kidney Association
See details and how to joinNCT06065852